Led · Equity · Mar 2026

Autonomous A2Z develops autonomous vehicle technologies with a hybrid engineering approach that combines rule-based algorithms and AI-driven decision systems aimed at achieving Level 4 autonomy. The company operates a research center in Pyeongchon, Gyeonggi, and runs autonomous mobility projects in markets including Singapore (in partnership with Grab), the United Arab Emirates, and Japan, where it has begun robotaxi trials. It has accumulated total funding of 122.5 billion won following the recent 40.5 billion won pre-IPO round and is preparing for a Kosdaq listing. Planned uses of capital include expanding domestic and international projects and procuring sensors, controllers, and vehicle components. Autonomous A2Z is preparing to participate in a large-scale pilot program led by the South Korea Ministry of Transport. The company says it aims to accelerate commercial deployment of Level 4 driverless vehicles and to build a global data network to support that goal.

Participated · Series C · Jun 2024

Nota AI develops on-device generative AI optimization and lightweighting technology through its NetsPresso platform, enabling AI models to run directly on edge devices. The company has established official partnerships with global tech firms including NVIDIA, ARM, Intel, STMicroelectronics and Renesas and holds contracts to provide optimization technology to leading AI semiconductor companies. Founded in 2015 and based in Seoul, Nota AI has expanded its customer base domestically and internationally and has received early backing from Naver D2SF. Cumulative funding since inception is approximately $42.6 million, and the company reports strong near-term revenue momentum—expecting first-half 2024 sales to exceed total 2023 sales and forecasting a 300% sales increase for 2024 versus the prior year. With the new funding, Nota AI plans to recruit top AI optimization talent, deepen collaborations with global AI semiconductor players, and extend its optimization technology into industries such as robotics and mobility. The company is preparing for an IPO in early 2025 with Mirae Asset Securities as lead underwriter. Nota is a compressed AI solutions and software optimization platform founded in 2015 that focuses on B2B and B2G markets. Its main product, NetsPresso, is an automatic model compression platform that downsizes computer vision models for edge and low-spec device deployment. Nota’s AI technology is applied in intelligent transportation, facial recognition, and security and surveillance through solutions such as Driver Monitoring System, Driver Authentication, and Smart Access Control System. In November 2021 Nota raised $14.7M in a Series B, bringing its total funding to $23M. The company plans to expand its global business, enhance its AI optimization technology, and strengthen its R&D team by recruiting additional top-tier talent. Nota is headquartered in Seoul, South Korea.

Participated · Series C · Apr 2024

Founded in 2019, Integration operates Medistream, a digital community that counts over 23,700 members—about 85% of all licensed Korean traditional medicine doctors. Building on this captive user base, the company has expanded into clinic-specific commerce for medical devices and consumables, proprietary traditional medicine brands such as Su, Lin Diet, and Acurex, and cloud-based EMR/CRM software. These services aim to streamline non-clinical workflows so practitioners can focus on patient care while boosting revenue. The domestic traditional medicine clinic market is estimated at ₩8 trn with 96 m annual patient visits, giving Integration a large addressable market. The firm’s branded product line generated ₩45.4 bn in revenue last year, growing 73% year-on-year. Future plans include elevating clinic infrastructure across Korea and taking its consumer health brands to global markets, positioning the company as a leading “K-Hanbang” (Korean traditional medicine) champion.